CIK 0001520262
- Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981007018
- Phone
- +353 17728000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale SVP, Chief Commercial Officer sold 10,417 shares at $28.10 ($292,740)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes SVP, Chief Commercial Officer gave up 2,845 shares (to pay taxes)
- 4 Open-market sale VP, Finance (Interim PAO) sold 2,559 shares at $29.65 ($75,874)
- 4 Shares withheld for taxes SVP, Chief Financial Officer gave up 2,587 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, CLO, Alkermes, Inc. gave up 3,414 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Corp Dev., Alkermes, Inc. gave up 1,811 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Chief Operating Officer gave up 3,880 shares (to pay taxes)
- 4 Shares withheld for taxes EVP R&D, Chief Medical Officer gave up 3,414 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes VP, Finance (Interim PAO) gave up 908 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Chief Commercial Officer gave up 3,156 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Corp Dev., Alkermes, Inc. gave up 1,929 shares (to pay taxes)
Page 8 of 67 · 1,323 filings